Ward from Clarivate says Pfizers acquisition of Metsera was its way of getting back into the game after the failure of its in-house GLP-1 molecule last year
Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange
Topical biglycan application in a murine model of Ehlers-Danlos syndrome

Contraindications Contraindications for this combination are the individual contraindications of each compound: GHK-Cu should be avoided if you have: Wilson's disease or other copper metabolism disorders Known allergy to copper or copper peptides Semaglutide should be avoided if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 Active or recent pancreatitis Pregnancy or breastfeeding Monitoring Recommendations For patients using GHK-Cu alongside semaglutide, we recommend: Standard semaglutide monitoring (metabolic panel, HbA1c, lipids at baseline and periodically) Copper and ceruloplasmin levels at baseline if there's any concern about copper metabolism Skin assessment at each follow-up to evaluate tissue response General nutritional assessment to ensure adequate micronutrient intake Monitoring and lab work Frequently Asked Questions Can GHK-Cu cause copper toxicity when used with semaglutide

Stable gastric pentadecapeptide BPC 157 as therapy after surgical detachment of the quadriceps muscle for muscle-to-bone reattachment in rats2025Musculoskeletal BPC 157 promoted quadriceps muscle-to-bone reattachment after surgical detachment in rats, with consistent healing confirmed via ultrasonic, MRI, biomechanical, and functional assessments